$2.200
+0.184 (+8.37%)Al cierre
Rentabilidad y márgenes de NAYA
Evaluating the bottom line, NAYA Biosciences Inc maintains a gross margin of 14.95%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -90.74%, while the net margin is -113.78%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively NAYA converts its operational activities into shareholder value.
Comparativa sectorial de NAYA
In the context of the broader market, NAYA competes directly with industry leaders such as OTRK and MNDR. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, NAYA's gross margin of 14.95% stands against OTRK's 36.99% and MNDR's 16.94%. Such benchmarking helps identify whether NAYA Biosciences Inc is trading at a premium or discount relative to its financial performance.
Financials
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.